Close Menu

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Siemens Healthineers' Atellica IM SARS-CoV-2 IgG (sCOVG) antibody test.

The chemiluminescent immunoassay is designed to detect immunoglobulin G against SARS-CoV-2 in serum and plasma samples. It runs on the Erlangen, Germany-based company's Atellica IM Analyzer.

The test may be used by laboratories CLIA-certified to perform moderate- or high-complexity tests, according to the FDA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

May
10
Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
13
Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.